David Steinberg
Stock Analyst at Jefferies
(2.79)
# 1,668
Out of 4,828 analysts
36
Total ratings
57.14%
Success rate
17.86%
Average return
Main Sectors:
Top Industries:
Stocks Rated by David Steinberg
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BHC Bausch Health Companies | Downgrades: Hold | $12 → $8 | $4.59 | +74.29% | 7 | Feb 6, 2025 | |
| PRGO Perrigo Company | Upgrades: Buy | $45 → $63 | $27.01 | +133.25% | 8 | Sep 30, 2021 | |
| SUPN Supernus Pharmaceuticals | Upgrades: Buy | $25 → $40 | $31.70 | +26.18% | 11 | Apr 13, 2021 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $151 → $188 | $97.78 | +92.27% | 5 | Oct 9, 2020 | |
| OCUL Ocular Therapeutix | Initiates: Buy | $8 | $7.06 | +13.31% | 1 | Mar 17, 2020 | |
| SCPH scPharmaceuticals | Maintains: Buy | $26 → $12 | $2.44 | +391.80% | 2 | Jun 14, 2018 | |
| OPTN OptiNose | Initiates: Buy | $405 | $9.39 | +4,213.10% | 1 | Nov 7, 2017 | |
| SVRA Savara | Initiates: Buy | $20 | $2.86 | +599.30% | 1 | Sep 22, 2017 |
Bausch Health Companies
Feb 6, 2025
Downgrades: Hold
Price Target: $12 → $8
Current: $4.59
Upside: +74.29%
Perrigo Company
Sep 30, 2021
Upgrades: Buy
Price Target: $45 → $63
Current: $27.01
Upside: +133.25%
Supernus Pharmaceuticals
Apr 13, 2021
Upgrades: Buy
Price Target: $25 → $40
Current: $31.70
Upside: +26.18%
Jazz Pharmaceuticals
Oct 9, 2020
Maintains: Buy
Price Target: $151 → $188
Current: $97.78
Upside: +92.27%
Ocular Therapeutix
Mar 17, 2020
Initiates: Buy
Price Target: $8
Current: $7.06
Upside: +13.31%
scPharmaceuticals
Jun 14, 2018
Maintains: Buy
Price Target: $26 → $12
Current: $2.44
Upside: +391.80%
OptiNose
Nov 7, 2017
Initiates: Buy
Price Target: $405
Current: $9.39
Upside: +4,213.10%
Savara
Sep 22, 2017
Initiates: Buy
Price Target: $20
Current: $2.86
Upside: +599.30%